The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease
Abstract
OBJECTIVES: A primary defect of the tight junctions and, hence, increased intestinal epithelial permeability has been proposed as a basic pathogenic event in Crohn's disease. Challenge of the mucosal immune system by the commensal gut flora would then result in chronic inflammation. Alternatively, increased permeability could be the result of inflammation. Our aim was to study intestinal permeability in refractory Crohn's disease before and after treatment with monoclonal chimeric antibodies directed against tumor necrosis factor (TNF) to investigate whether the abnormal permeability persists after control of inflammation. METHODS: Twenty-three patients with active Crohn's disease were evaluated before and 4 wk after a single infusion of 5 mg/kg infliximab. Intestinal permeability was studied by measurement of urinary excretion of 51Cr-EDTA after oral intake. RESULTS: The increased permeation of 51Cr-EDTA through the small intestine (1.63% interquartile range [IQR] 1.06-2.07) and the overall permeation (3.27% IQR 2.40-4.38) before therapy decreased significantly after infliximab infusion to values (1.04% IQR 0.74-1.54 and 2.42% IQR 2.03-2.80, respectively) in the range of those found in normal volunteers (1.12% IQR 0.85-1.58 and 2.28% IQR 1.88-2.86, respectively). CONCLUSION: Inhibiting the proinflammatory cytokine tumor necrosis factor dramatically reduces gut inflammation and largely restores the gut barrier in Crohn's disease. Our data confirm the central role of TNF in gut barrier modulation in inflammatory conditions in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targan, S. R., Hanauer, S. B., van Deventer, S. J. H., Mayer, L., Present, D. H., Braakman, T., DeWoody, K. L., Schaible, T. F., & Rutgeerts, P. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371502 · Cited by 3,135
Self-citationSellon, R. K., Tonkonogy, S., Schultz, M., Dieleman, L. A., Grenther, W., Balish, E., Rennick, D. M., & Sartor, R. B. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5224-5231.1998 · Cited by 1,483
Intestinal permeability and the prediction of relapse in Crohn's disease
Wyatt, J., Vogelsang, H., Hübl, W., Waldhoer, T., & Lochs, H. (1993) · The Lancet · doi:10.1016/0140-6736(93)90882-h · Cited by 626
Research works printed but not linked: 38
- Shorter R.G., 1972, Am J Dig Dis, 17, 1024, 10.1007/BF02239143 · DOI · Paper page
- Madara J.L., 1987, J Membr Biol, 100, 149, 10.1007/BF02209147 · DOI · Paper page
- Marin M.L., 1983, Am J Gastroenterol, 78, 537
- Ramage J.K., 1988, Gastroenterology, 94, 1368, 10.1016/0016-5085(88)90675-0 · DOI
- Bjarnason I., 1983, Gastroenterology, 85, 318, 10.1016/0016-5085(83)90317-7 · DOI · Paper page
- Teahon K., 1996, Gut, 38, 864, 10.1136/gut.38.6.864 · DOI
- Jenkins R.T., 1987, Am J Gastroenterol, 82, 1159
- Jenkins R.T., 1988, Clin Invest Med, 11, 151
- Ainsworth M., 1989, Scand J Gastroenterol, 24, 993, 10.3109/00365528909089246 · DOI
- Pironi L., 1990, Dig Dis Sci, 35, 582, 10.1007/BF01540405 · DOI
- Adenis A., 1992, Gut, 33, 678, 10.1136/gut.33.5.678 · DOI
- Soderholm J.D., 1999, Gut, 44, 96, 10.1136/gut.44.1.96 · DOI · Paper page
- Soderholm J., 1999, Gastroenterology, 117, 65, 10.1016/S0016-5085(99)70551-2 · DOI · Paper page
- Peeters M., 1994, Dig Dis Sci, 39, 2170, 10.1007/BF02090367 · DOI
- Hollander D., 1986, Ann Intern Med, 105, 883, 10.7326/0003-4819-105-6-883 · DOI · Paper page
- Peeters M., 1997, Gastroenterology, 113, 802, 10.1016/S0016-5085(97)70174-4 · DOI · Paper page
- May G.R., 1993, Gastroenterology, 104, 1627, 10.1016/0016-5085(93)90638-S · DOI · Paper page
- Hollander D., 1993, Gastroenterology, 104, 1848, 10.1016/0016-5085(93)90668-3 · DOI
- Teahon K., 1991, Gastroenterology, 101, 84, 10.1016/0016-5085(91)90463-U · DOI · Paper page
- 10.1046/j.1365-2036.1997.t01-1-00192.x · DOI
- Sanderson I., 1987, Gut, 28, 1073, 10.1136/gut.28.9.1073 · DOI · Paper page
- Miki K., 1998, J Pediatr, 133, 750, 10.1016/S0022-3476(98)70145-3 · DOI
- 10.1016/0140-6736(91)90663-A · DOI · Paper page
- D'Haens G.R., 1998, Gastroenterology, 114, 262, 10.1016/S0016-5085(98)70476-7 · DOI · Paper page
- Harper P., 1985, Gut, 26, 279, 10.1136/gut.26.3.279 · DOI · Paper page
- Fasoli R., 1990, Br J Surg, 77, 616, 10.1002/bjs.1800770606 · DOI
- Best W.R., 1976, Gastroenterology, 70, 439, 10.1016/S0016-5085(76)80163-1 · DOI · Paper page
- Peeters M., 1994, Gut, 35, 1404, 10.1136/gut.35.10.1404 · DOI
- Dullemen H.M., 1995, Gastroenterology, 109, 129, 10.1016/0016-5085(95)90277-5 · DOI · Paper page
- D'Haens G., 1999, Gastroenterology, 116, 1029, 10.1016/S0016-5085(99)70005-3 · DOI · Paper page
- Baert F., 1999, Gastroenterology, 116, 22, 10.1016/S0016-5085(99)70224-6 · DOI · Paper page
- Mowat A.M., 1997, Immunol Rev, 156, 145, 10.1111/j.1600-065X.1997.tb00966.x · DOI · Paper page
- Colgan S.P., 1994, J Immunol, 153, 2122, 10.4049/jimmunol.153.5.2122 · DOI · Paper page
- 10.1074/jbc.271.13.7460 · DOI
- Youakim A., 1999, Am J Physiol, 276, G1279
- McKay D.M., 1997, J Immunol, 159, 2382, 10.4049/jimmunol.159.5.2382 · DOI
- Schmitz H., 1999, J Cell Sci, 112, 137, 10.1242/jcs.112.1.137 · DOI · Paper page
- Zareie M., 1998, Am J Physiol, 275, C932, 10.1152/ajpcell.1998.275.4.C932 · DOI
Cited by
Intestinal mucosal barrier function in health and disease
Turner, J. R. (2009) · Nature reviews. Immunology · doi:10.1038/nri2653 · Cited by 3,952
Signalling pathways of the TNF superfamily: a double-edged sword
Aggarwal, B. B. (2003) · Nature Reviews Immunology · doi:10.1038/nri1184 · Cited by 2,793
Intestinal barrier function: molecular regulation and disease pathogenesis
Groschwitz, K. R., & Hogan, S. P. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.05.038 · Cited by 1,775
The intestinal epithelial barrier: a therapeutic target?
Odenwald, M. A., & Turner, J. R. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.169 · Cited by 1,288
Regulation of Tight Junction Permeability by Intestinal Bacteria and Dietary Components1,2
Ulluwishewa, D., Anderson, R. C., McNabb, W. C., Moughan, P. J., Wells, J. M., & Roy, N. C. (2011) · The Journal of Nutrition · doi:10.3945/jn.110.135657 · Cited by 1,177
Metadata
- Authors
- Suenaert, P.
- Venue
- The American Journal of Gastroenterology
- Published
- 2002-08
- Volume
- 97
- Issue
- 8
- Pages
- 2000-2004
- ISSN
- 0002-9270 (ISSN-L)
- OpenAlex
- W2085429049
- Cited by
- 399
- References
- 3
- FWCI
- 5.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease. https://app.cochat.ai/papers/10.1016/s0002-9270(02)04271-5
- The paper
- Suenaert, P. (2002). Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease. The American Journal of Gastroenterology. https://doi.org/10.1016/s0002-9270(02)04271-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.